BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23416667)

  • 1. Can the SBIR and STTR programs advance research goals?
    Ceulemans S; Kolls JK
    Nat Immunol; 2013 Mar; 14(3):192-5. PubMed ID: 23416667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographically-related outcomes of U.S. funding for small business research and development: Results of the research grant programs of a component of the National Institutes of Health.
    Onken J; Aragon R; Calcagno AM
    Eval Program Plann; 2019 Dec; 77():101696. PubMed ID: 31404866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the government/industry interface--the NIH SBIR STTR program.
    Etzler K
    J Dent Hyg; 2009; 83(4):210-1. PubMed ID: 19909652
    [No Abstract]   [Full Text] [Related]  

  • 4. Creative partnerships for funding nursing research.
    McCann JJ; Hills EB; Zauszniewski JA; Smith CE; Farran CJ; Wilkie DJ
    West J Nurs Res; 2011 Feb; 33(1):79-105. PubMed ID: 20719996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SBIR program. Researchers fight against bigger slice to small business.
    Mervis J
    Science; 2009 Jul; 325(5936):18. PubMed ID: 19574355
    [No Abstract]   [Full Text] [Related]  

  • 6. Investor initiatives program: Public-private partnerships to expedite commercialization for NCI-funded small business entrepreneurs.
    Connors B; Lou XJ; Subedee A; Zhang K; Weingarten M; Narayanan D
    Clin Transl Sci; 2021 Nov; 14(6):2124-2131. PubMed ID: 34387931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using database linkages to measure innovation, commercialization, and survival of small businesses.
    Onken J; Miklos AC; Dorsey TF; Aragon R; Calcagno AM
    Eval Program Plann; 2019 Dec; 77():101710. PubMed ID: 31518846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts.
    Zakeri K; Narayanan D; Vikram B; Evans G; Coleman CN; Prasanna PGS
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):188-196. PubMed ID: 30583040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Institutes of Health phase I, Small Business Innovation Research applications: fiscal year 1983 results.
    Vener KJ
    Fed Proc; 1985 Aug; 44(11):2679-84. PubMed ID: 4018273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Funding innovative science.
    Hyman AA
    Science; 2013 Jan; 339(6116):119. PubMed ID: 23307707
    [No Abstract]   [Full Text] [Related]  

  • 11. New tax credit program aims to revive ailing biotech research.
    Clin Transl Sci; 2010 Oct; 3(5):200. PubMed ID: 21500422
    [No Abstract]   [Full Text] [Related]  

  • 12. Merit, quality, and the SBIR program.
    Whalen RL
    Science; 1996 Jun; 272(5269):1725. PubMed ID: 8650560
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantum grants: request for applications from the NIBIB.
    Harrington DP
    J Am Coll Radiol; 2006 Jun; 3(6):398-9. PubMed ID: 17412092
    [No Abstract]   [Full Text] [Related]  

  • 14. Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community.
    Snyder HM; Bain LJ; Egge R; Carrillo MC
    Alzheimers Dement; 2013 Jul; 9(4):466-71. PubMed ID: 23809367
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the National Cancer Act on grant support.
    Kalberer JT
    Cancer Res; 1975 Mar; 35(3):472-81. PubMed ID: 1090361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small businesses to get bigger slice of US research pie.
    Anderson C
    Nature; 1992 Oct; 359(6395):470. PubMed ID: 1406961
    [No Abstract]   [Full Text] [Related]  

  • 17. The Bayh-Dole Act turns 30.
    Loise V; Stevens AJ
    Sci Transl Med; 2010 Oct; 2(52):52cm27. PubMed ID: 20926832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. science policy. Risky business.
    Mervis J
    Science; 2004 Oct; 306(5694):220-1. PubMed ID: 15472055
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteomics. Public-private group maps out initiatives.
    Kaiser J
    Science; 2002 May; 296(5569):827. PubMed ID: 11988548
    [No Abstract]   [Full Text] [Related]  

  • 20. Visceral viewpoints. Goals and controls - grants and contracts.
    Spiro HM
    N Engl J Med; 1975 Sep; 293(11):545-7. PubMed ID: 1152879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.